Status:
UNKNOWN
Localization of Point A in Cervical Cancer
Lead Sponsor:
Mackay Memorial Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
30-75 years
Phase:
NA
Brief Summary
Point A, the major critical point for dose specification of intracavitary brachytherapy, is defined as the crossing of uterine artery and ureter in treatment of cervical cancer. However, the currently...
Detailed Description
Radiation therapy (RT), with a relevant integration of external beam radiotherapy (EBRT) and intracavitary brachytherapy (ICBT), is an important part in the treatment of cervical cancer. Even though c...
Eligibility Criteria
Inclusion
- Female,
- Carvical cancer proven by pathology,
- Indicated for lymph node sampling
Exclusion
- Patient refuse lymph node sampling,
- History of allergy to metal materials
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00319462
Start Date
November 1 2006
End Date
April 1 2007
Last Update
April 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology
Taipei, Taiwan, 104